Itraconazole (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the Itraconazole drug offered from Accord Healthcare Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
NON-PROPRIETARY NAME: | ITRACONAZOLE |
SUBSTANCE NAME: | ITRACONAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
Itraconazole HUMAN PRESCRIPTION DRUG Details:
Item Description | Itraconazole from Accord Healthcare Inc. |
LABELER NAME: | Accord Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-271_5494da08-60a4-4a1e-e054-00144ff88e88 |
PRODUCT NDC: | 16729-271 |
APPLICATION NUMBER: | ANDA205991 |
Other ITRACONAZOLE Pharmaceutical Manufacturers / Labelers: